None listed
Conditions
Brief summary
Leaky gut is a possible precipitant of inflammatory bowel diseases. We determine whether leaky gut can be identified in patients with Crohn's disease and ulcerative colitis in comparison with non-IBD controls using confocal endomicroscopy, which can identify microscopic barrier function of the bowel mucosa. Patients are followed longitudinally to determine if they improve or flare requiring treatment escalation.
Interventions
Confocal endomicroscopy - an endoscopic procedure that incorporates a laser microscope on the tip of the endoscope - visualising the microscopic structure of the gut lining. The confocal laser microscope enlarges the mucosa image by 1,000-fold. The procedure is performed using standard sedation procedure. Procedure duration lasts for 15 - 30 minutes, similar to a standard colonoscopy. Inflammatory bowel disease patients requiring colonoscopy will be invited to participate. All patients will be assessed for clinical disease activity (CDAI or Mayo), biomarkers of inflammation (ESR, CRP), medical and surgical therapy. Controls will be non-IBD patients requiring colonoscopy eg for screening for family history, minor gastrointestinal symptoms where IBD is finally excluded, Fe deficiency where an alternative diagnosis is eventually made (eg menorrhagia). All subjects undergo confocal endomicroscopy.
Sponsors
Eligibility
Inclusion criteria
Patients requiring colonoscopy and consenting to the confocal colonoscopy study will be recruited. Age 16 - 80 Males and females Known IBD and non-IBD controls (eg those investigated for iron deficiency but shows no changes of IBD on colonoscopy)
Exclusion criteria
Severe flare of IBD making colonoscopy dangerous Documented allergy to fluorescein. Pregnancy and lactation-breast-feeding